新诊断与复发胶质母细胞瘤肿瘤免疫环境比较及配对患者分析
该研究分析24例胶质母细胞瘤患者(初诊13例、复发11例,其中5例有配对标本)的临床数据与组织标本,比较初诊与复发时多种免疫生物标志物表达及肿瘤浸润免疫细胞分布。结果发现复发肿瘤的肿瘤浸润淋巴细胞、巨噬细胞及PD-L1、PD-1表达显著高于初诊肿瘤和癫痫手术良性脑标本,且复发时CD4或CD8高浸润分别与更差预后相关。
要点
- 复发胶质母细胞瘤的肿瘤浸润淋巴细胞和巨噬细胞显著多于初诊肿瘤及癫痫手术良性脑标本。
- 复发肿瘤PD-L1和PD-1表达显著高于初诊肿瘤及良性脑标本。
- 配对标本中CD8与CD4比值从诊断到复发保持恒定。
核心结论
- 肿瘤浸润淋巴细胞和肿瘤相关巨噬细胞倾向于聚集在血管周围区域,且在复发胶质母细胞瘤中比新诊断胶质母细胞瘤更丰富。
研究设计与样本
- 研究分析了24例胶质母细胞瘤患者的临床数据和组织标本,其中初诊13例、复发11例,包括5例同时具备初诊与复发配对标本的患者。
- 研究比较了患者初诊与复发胶质母细胞瘤中多种免疫生物标志物的表达水平,并在肿瘤内和血管周围区域评估肿瘤浸润免疫细胞的分布模式。
主要发现
- 复发胶质母细胞瘤的肿瘤浸润淋巴细胞和巨噬细胞显著多于初诊肿瘤及癫痫手术良性脑标本,PD-L1和PD-1表达也更高。
- 5例配对标本中TILs和巨噬细胞的变化模式与未配对患者一致,而配对组织中CD8与CD4比值从诊断到复发保持恒定。
- 初诊时TILs、巨噬细胞、PD-1或PD-L1+细胞水平与总生存期无相关性。
- 复发肿瘤中TILs、巨噬细胞和PD-1+细胞在肿瘤内和血管周围区域均增加,且肿瘤内分布水平高于血管周围区域。
- 复发时CD4或CD8高浸润分别与更差预后相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glioblastoma (GBM) is the most lethal primary brain tumor in adult patients. The disease progression, response to chemotherapy and radiotherapy at initial diagnosis, and prognosis are profoundly associated with the tumor microenvironment, especially the features of tumor-infiltrating immune cells (TII). Recurrent GBM is even more challenging to manage. Differences in the immune environment between newly diagnosed and recurrent GBM and an association with tumor prognosis are not well defined. METHODS: To address this knowledge gap, we analyzed the clinical data and tissue specimens from 24 GBM patients (13 at initial diagnosis and 11 at recurrence). The expression levels of multiple immunobiological markers in patients' GBM at initial diagnosis versus at recurrence were compared, including five patients with both specimens available (paired). The distribution patterns of TII were evaluated in both the intratumoral and perivascular regions. RESULTS: We found that tumors from recurrent GBM have significantly more tumor-infiltrating lymphocytes (TILs) and macrophages and higher PD-L1 and PD-1 expression than tumors at primary diagnosis and benign brain specimens from epilepsy surgery. The pattern changes of the TILs and macrophages of the five paired specimens were consistent with the unpaired patients, while the CD8 to CD4 ratio remained constant from diagnosis to recurrence in the paired tissues. The levels of TILs, macrophages, PD-1 or PD-L1+ cells at initial diagnosis did not correlate with OS. TILs, macrophages, and PD-1+ cells were increased in recurrent tumors both in intratumoral and perivascular areas, with higher distribution levels in intratumoral than perivascular regions. Higher CD4 or CD8 infiltration at recurrence was associated with a worse prognosis, respectively. CONCLUSIONS: Our study elucidated that TIL and TAM tend to accumulate in perivascular region and are more abundant in recurrent GBM than newly diagnosed GBM.
引用
- Wang F, Cathcart SJ, DiMaio DJ, et al. Comparison of tumor immune environment between newly diagnosed and recurrent glioblastoma including matched patients. J Neurooncol. 2022. PMID: 35754074. doi:10.1007/s11060-022-04053-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。